Live Breaking News & Updates on Salonpas Pain Relief Patch Large

Stay updated with breaking news from Salonpas pain relief patch large. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dietary Supplement and Personal Care Product Regulatory and Litigation Highlights – March 2021 | Kelley Drye & Warren LLP

To embed, copy and paste the code into your website or blog:
Welcome to our curated selection of highlights of regulatory and litigation developments in the dietary supplement and personal care product industries for March 2021. In case you were wondering what pain relief, teeth whitening, and CBD have in common (and, who wasn’t?) it seems that one year into the pandemic, these are the advertising battles being fought in multiple forums. Read on…
National Advertising Division
NAD addressed some unique superiority and comparative claims in the OTC drug space in finding that Hisamitsu America, Inc., supported its duration claims that Salonpas Pain Relief Patch Large “works for up to 12 hours” and “provides relief for up to 12 hours.” However, NAD found that comparative claims such as “All OTC pain relievers, including Voltaren, have one thing in common. None are proven stronger or more effective against pain than Salonpas Pain Relief Patch Large” and � ....

New York , United States , Day Energy Greens , Elanco Animal Health Inc , Colgate Palmolive , Palmolive Company , Naturmed Inc , Reckitt Bensicker , National Advertising Division , Infinite Product Co , Orthopaedic Research Society , Hisamitsu America Inc , Llccd Cal , Hisamitsu America , Salonpas Pain Relief Patch Large , Salonpas Pain Relief Patch , Colgate Palmolive Company , Optic White Renewal Toothpaste , Goli Nutrition , Cosmetics Act , Eastern District , Bactolac Pharmaceutical , Day Energy , Free Advanced , Look Good Feel , Southern District ,

NAD Finds Salonpas Duration Claim Supported; Recommends Hisamitsu America Discontinue Comparative Pain Relief, Onset of Action, Range of Motion Claims

NAD Finds Salonpas Duration Claim Supported; Recommends Hisamitsu America Discontinue Comparative Pain Relief, Onset of Action, Range of Motion Claims
News provided by
Share this article
Share this article
NEW YORK, March 10, 2021 /PRNewswire/ The National Advertising Division (NAD) of BBB National Programs determined that Hisamitsu America, Inc. supported its duration claims that Salonpas Pain Relief Patch Large works for up to 12 hours and provides relief for up to 12 hours. NAD also determined that Hisamitsu provided a reasonable basis for the challenged claims comparing the Salonpas patch s regulatory pathway to competitor products. However, NAD has recommended that Hisamitsu discontinue the following parity and product performance claims: ....

Hisamitsu America Inc , National Programs , National Advertising Division , Hisamitsu America , Salonpas Pain Relief Patch Large , Glaxosmithkline Consumer Healthcare , Voltaren Topical , New Drug , Salonpas Pain Relief Patch , New Drug Applications , Better Business Bureaus , Bbb National Programs , ஹிசாமிட்சு அமெரிக்கா இன்க் , தேசிய ப்ரோக்ர்யாம்ஸ் , ஹிசாமிட்சு அமெரிக்கா , கிளாக்சோஸ்மித்க்லைன் நுகர்வோர் சுகாதாரம் , புதியது மருந்து , புதியது மருந்து பயன்பாடுகள் , சிறந்தது வணிக பணியகங்கள் , பிபிபி தேசிய ப்ரோக்ர்யாம்ஸ் ,